MHVI Interventional Fellow Wins Young Investigator Award
At the 2015 Transcatheter Cardiovascular Therapeutics meeting, Toby Rogers, BM BCh, was honored with the Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award for clinical and academic excellence. Rogers is an interventional fellow at MedStar Heart & Vascular Institute and a research fellow at the National Heart, Lung and Blood Institute.
Augusto Pichard, MD, senior consultant for MHVI’s Cardiac Intervention and Structural Heart Diseases program, says, “Toby’s NIH work is unprecedented, and has already been proven in animal models. His out-of-the-box thinking will lead to new and enhanced treatments for complex heart disease. We’re excited to be working with him.”
MedStar Health Joins Maryland's Angioplasty External Review Group
This fall, Mun K. Hong, MD, FACC, chief of Cardiology at MedStar Southern Maryland Hospital Center, became MedStar Health’s representative to the Maryland Academic Consortium for Percutaneous Coronary Intervention Appropriateness and Quality (MACPAQ). Featuring cardiology experts from Johns Hopkins, University of Maryland Medicine and MedStar, the professional quality assurance monitoring program will conduct external peer review for angioplasty programs throughout the state.
“One of the chief goals is to identify unnecessary or inappropriate use of stents, by objectively assessing case selection, performance and reporting mechanisms for each hospital and physician performing PCI,” says Dr. Hong, an interventional cardiologist who was recommended for the MACPAQ role by Stuart F. Seides, MD, physician executive director of MedStar Heart & Vascular Institute. “But the process is also designed to inform and educate so that individual physicians, hospitals and patient outcomes can improve.”
Reviews are blinded, confidential, cross-institutional and non-punitive. Records submitted to MACPAQ must comprise 5 percent of all angioplasties performed at each hospital by a mix of practitioners over the previous six months. For record selection, each hospital uses the same sophisticated MACPAQ computer system to assure randomization; each record pulled for review is then assigned a unique number. Upon receipt by MACPAQ, records are further blinded by redacting all patient, physician and hospital identifiers. Following peer review, findings and comments are then sent to MACPAQ and the hospital where the procedures occurred for their information.
Maryland mandated the compulsory external review of both angioplasty practitioners and the hospitals in August 2014. In addition to MedStar Southern Maryland, the ruling also affects MedStar Union Memorial Hospital and MedStar Franklin Square Medical Center.
Joint MedStar/Cleveland Clinic CME a Success
On Oct. 30, more than 100 adult primary care physicians, cardiologists, cardiovascular surgeons, nurse practitioners and physician assistants attended the MedStar Heart & Vascular Institute and Cleveland Clinic Heart and Vascular Institute’s day-long CME in Baltimore, focused on Contemporary Management of Cardiovascular Disease. Attendees came from Baltimore, Delaware, Southern Maryland and the Washington, D.C., area.
The course delivered an update on the management of common, yet complex cardiovascular conditions. Paul J. Corso, MD, FACC, FACS, chair, Cardiac Surgery, MedStar Heart & Vascular Institute, and one of the course directors, said, “It was a very successful meeting based on the laudatory comments we’ve received. The audience participation in the Q&A was gratifying to all of us. Dr. Svensson and I have already begun to discuss next year’s joint conference.”
In addition to Dr. Corso, Lars G. Svensson, MD, PhD, chair, Heart & Vascular Institute, Cleveland Clinic and Ron Waksman, MD, director, Cardiovascular Research Network, MedStar Heart & Vascular Institute, were course directors. Faculty for the CME was from Cleveland Clinic, MedStar Washington Hospital Center and MedStar Union Memorial Hospital.